Carlos  Costa net worth and biography

Carlos Costa Biography and Net Worth

Carlos brings over 20 years of experience in organizational and human capital management acquired from working in the biotech, pharma and consumer goods industries around the world.

Prior to joining the company, Carlos held various roles of increasing responsibility at Biogen, in multiple areas and geographies ranging from human resources business partner for Spain, Portugal, and Italy, to HR lead for global commercial functions in the United States and the Emerging Markets region. In his most recent role at Biogen, Carlos was the head of human resources for Europe, Canada, and International Partner Markets.

Before joining Biogen, Carlos spent 10 years serving as HR business partner in companies like Gillette and Roche, where he built teams, led transformations and served as strategic partner to the business.

Carlos holds a BS in law from UNED in Spain and received his human resources master’s degree from EADA in Barcelona. He also holds a PDD from IE Instituto de Empresa, Madrid and the Executive Leadership Program at Harvard Business School, Boston.

How old is Carlos Costa?

Mr. Costa is currently 51 years old. There are 6 older executives and no younger executives at Foghorn Therapeutics. The oldest executive at Foghorn Therapeutics is Dr. Steven F. Bellon Ph.D., Chief Scientific Officer, who is 59 years old. Learn More on Carlos Costa's age.

How do I contact Carlos Costa?

The corporate mailing address for Mr. Costa and other Foghorn Therapeutics executives is , , . Foghorn Therapeutics can also be reached via phone at 617-586-3100 and via email at [email protected]. Learn More on Carlos Costa's contact information.

Has Carlos Costa been buying or selling shares of Foghorn Therapeutics?

Carlos Costa has not been actively trading shares of Foghorn Therapeutics in the last ninety days. Most recently, Carlos Costa sold 857 shares of the business's stock in a transaction on Monday, September 23rd. The shares were sold at an average price of $10.17, for a transaction totalling $8,715.69. Learn More on Carlos Costa's trading history.

Who are Foghorn Therapeutics' active insiders?

Foghorn Therapeutics' insider roster includes Samuel Agresta (insider), and Carlos Costa (insider). Learn More on Foghorn Therapeutics' active insiders.

Carlos Costa Insider Trading History at Foghorn Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/23/2024Sell857$10.17$8,715.69View SEC Filing Icon  
9/20/2024Sell35,756$10.04$358,990.24View SEC Filing Icon  
See Full Table

Carlos Costa Buying and Selling Activity at Foghorn Therapeutics

This chart shows Carlos Costa's buying and selling at Foghorn Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Foghorn Therapeutics Company Overview

Foghorn Therapeutics logo
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It develops FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM that is in phase I for the treatment of relapsed and/or refractory acute myeloid leukemia/myelodysplastic syndrome. The company is also developing therapies for mutant cancers, such as Non-Small Cell Lung, bladder, endometrial, colorectal, and melanoma cancers; and dependent cancers, including prostate cancer and diffuse large b-cell lymphoma. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $4.58
Low: $4.50
High: $4.81

50 Day Range

MA: $4.43
Low: $3.53
High: $5.02

2 Week Range

Now: $4.58
Low: $2.94
High: $7.42

Volume

164,807 shs

Average Volume

196,486 shs

Market Capitalization

$259.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.04